OTCMKTS:EMBI Emerald Bioscience (EMBI) Stock Price, News & Analysis $0.71 -0.01 (-0.96%) As of 06/17/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Emerald Bioscience Stock (OTCMKTS:EMBI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Emerald Bioscience alerts:Sign Up Key Stats Today's Range$0.71▼$0.7750-Day Range$0.71▼$1.0652-Week Range$0.02▼$0.20Volume78,346 shsAverage Volume14.24 million shsMarket Capitalization$190.73 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Emerald Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is based in San Diego, California. Read More Receive EMBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Bioscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EMBI Stock News HeadlinesEmerald Bioscience (OTCMKTS:EMBI) Trading Down 5.4% - What's Next?June 10, 2026 | americanbankingnews.comPIMCO Emerging Markets Bond InstlSeptember 26, 2024 | morningstar.comMA 3M Oz. Historical Gold Resource And A Market That Hasn't Caught UpOne Canadian junior explorer controls a gold and copper system in British Columbia's Kootenay Golden Arc - a district with over 4 million ounces of historical production. Surrounded by major operators including Coeur Mining and Centerra, the project holds a historical resource estimated at 3.31 million ounces of gold. With funding and permits in place for an active drill program and an updated NI 43-101 resource targeted for 2027, the setup offers multiple near-term catalysts - all against a backdrop of gold near record highs and a structurally short copper market.June 18 at 1:00 AM | Wall Street Logic (Ad)GMO Emerging Country Debt Fund Other (GMOQX) Stock Price, Quote, News & Analysis - Seeking AlphaAugust 15, 2024 | seekingalpha.comSprint Bioscience AB SPRINTApril 19, 2024 | morningstar.comMCannabis Bioscience Stock (OTC:CBIH), Quotes and News SummaryApril 16, 2024 | benzinga.comDaré Bioscience, Inc. (DARE)February 21, 2024 | finance.yahoo.comStar Lake Bioscience Co. Ltd. Guangdong Zhaoqing AJanuary 17, 2024 | wsj.comSee More Headlines EMBI Stock Analysis - Frequently Asked Questions How have EMBI shares performed this year? Emerald Bioscience's stock was trading at $0.6603 on January 1st, 2026. Since then, EMBI shares have increased by 7.8% and is now trading at $0.7115. How do I buy shares of Emerald Bioscience? Shares of EMBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Emerald Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Emerald Bioscience investors own include Fulcrum Therapeutics (FULC), Gold Resource (GORO), Meta Platforms (META), Heatwurx (PCSA), Akero Therapeutics (AKRO) and Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:EMBI CIKN/A Webwww.emeraldbio.life Phone949-336-3443FaxN/AEmployees4Year Founded2012Profitability EPS (Trailing Twelve Months)($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$1.05 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-347.62% Debt Debt-to-Equity Ratio0.43 Current Ratio3.59 Quick Ratio3.59 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares268,074,000Free FloatN/AMarket Cap$190.73 million OptionableNot Optionable Beta0.43 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:EMBI) was last updated on 6/18/2026 by MarketBeat.com Staff. From Our PartnersThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredChina can’t stop buying gold. Here’s why that mattersChina has made 18 consecutive months of central bank gold purchases - and analysts believe the official number...Traders Agency | SponsoredA 3M Oz. Historical Gold Resource And A Market That Hasn't Caught UpOne Canadian junior explorer controls a gold and copper system in British Columbia's Kootenay Golden Arc - a d...Wall Street Logic | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredHopeless About Retirement? Hopeless and Helpless Aren’t the Same ThingYour retirement date didn't move once - it moved slowly, then repeatedly, until the shift felt normal. That's ...Golden Portfolio | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Bioscience Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emerald Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EMBI Stock Alerts